PROPYLENE GLYCOL

Molecular Excipient

Mwt. LogP HBD HBA PSA RB CSP3
76.0 -0.6 2 2 40.0 1 1.0
CAS
57556
UNII
6DC9Q167V3
SYNONYMS
ZINC ID(s)
Availability
Present in 80 ZINC catalogs

Known Active Genes

There has not been any activity reported at 10μM or less for this excipient (per ChEBML)

Clinical Trials

This compound has been an intervention in the following clincial trials (per clinicaltrials.gov).
Code Date Title Phase Status
NCT00493662 Cross-Over Evaluation of Two Lubricating Eye Drops Phase 4 Completed
NCT00001036 The Safety and Effectiveness of a Type of Interleukin-2 Plus Zidovudine Plus Thymosin in HIV-Positive Patients With and Without Symptoms of Infection Phase 1 Completed
NCT00000664 Safety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine in HIV Positive, Asymptomatic and Symptomatic Individuals Phase 1 Completed
NCT00483795 Pilot Evaluation of Two Multipurpose Solutions in Regards to Corneal Staining Phase 4 Completed
NCT02292459 2015-12-01 Efficacy and Safety of Polyethylene Glycol 3350 (PEG 3350) for Relief of Constipation (MK-8114-005) Phase 3 Not Yet Recruiting
NCT02352987 2015-03-01 Effect of Neem Extract, Propylene Glycol and Salicylic Acid Combination in the Treatment of Arsenical Palmar Keratosis Phase 2 Not Yet Recruiting
NCT02396017 2015-03-01 Split-dose Versus Single-dose Polyethylene Glycol Regimen for Capsule Endoscopy Phase 4 Recruiting
NCT02359825 2015-02-01 Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function Phase 1 Not Yet Recruiting
NCT02337413 2015-01-01 Urotherapy vs. Urotherapy With Constipation Treatment for Nocturnal Enuresis Phase 4 Not Yet Recruiting
NCT02336906 2015-01-01 Urotherapy vs. Urotherapy With Constipation Treatment for Children With Lower Urinary Tract Dysfunction Phase 4 Not Yet Recruiting
NCT02228616 2014-10-01 Efficacy and Safety of Prucalopride in Combination With Polyethylene Glycol or Lactulose in Women With Chronic Constipation Phase 4 Recruiting
NCT02254629 2014-07-01 The Effects of Laxative-probiotic Sequential Treatment in the IBS Patients Phase 1 Active, Not Recruiting
NCT02126644 2014-05-01 The Efficacy and Safety of a Single 70% Glycolic Acid Peel With Vitamin C for the Treatment of Photoaging Phase 2 Not Yet Recruiting
NCT02126657 2014-05-01 The Efficacy and Safety of a Single 70% Glycolic Acid Peel With Vitamin C for the Treatment of Acne Scars Phase 2 Not Yet Recruiting
NCT02073552 2014-05-01 Colon Cleansing Quality of Polyethylene Glycol Compared With Polyethylene Glycol Plus Ascorbic Acid. Phase 4 Recruiting
NCT01928862 2014-03-01 Efficacy and Safety of Prepopik™ in Children for Overall Colon Cleansing in Preparation for Colonoscopy Phase 1/Phase 2 Recruiting
NCT02102373 2014-03-01 Evaluation of Two Different Diet Regimen Prior to Colonoscopy in Children Phase 2 Recruiting
NCT01969435 2014-03-01 Study of Melphalan HCl for Injection (Propylene Glycol-free), Carmustine, Etoposide, Cytarabine (BEAM Regimen) and Autologous Stem Cell Transplantation for Lymphoma Phase 2 Recruiting
NCT02070341 2014-02-01 Patient Tolerability and Efficacy of Bowel Preparation With Split Dose Picosalax vs. Split Dose PEG Phase 4 Recruiting
NCT01887158 2013-07-01 Efficacy of 2-Liter Mixed Preparation With Bisacodyl Plus Polyethylene Glycol and 4-Liter Polyethylene Glycol for Colon Cleansing in Patients With Prior History of Colorectal Resection Phase 4 Completed
NCT01875744 2013-06-01 Polyethylene Glycol for Childhood Constipation Phase 4 Recruiting
NCT01840553 2013-05-01 Efficacy and Safety Study of Sodium Phosphate Tablets vs PEG for Bowel Cleansing Phase 3 Completed
NCT02322879 2013-05-01 Protective Effects of Propylene Glycol in Daily Acetaminophen Dosing Phase 4 Recruiting
NCT01853709 2013-05-01 Multidisciplinary Approach Versus Conventional Approach in Colonic Preparation of Hospitalized Patients Phase 4 Not Yet Recruiting
NCT01865916 2013-04-01 2L Oral Bi-PegLyte Versus 2L Oral MoviPrep Regimen for Outpatient Colonic Preparation Phase 4 Recruiting
NCT01885104 2013-04-01 Safety and Tolerability of Oral Polyethylene Glycol (PEG 3350) Solution in Participants With Constipation (MK-8114-003) Phase 2 Completed
NCT01660633 2012-12-01 Safety and Efficacy Study of High Dose Melphalan HCL for Injection (Propylene Glycol-Free) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation Phase 2/Phase 3 Active, Not Recruiting
NCT01627171 2012-09-01 Colonoscopy Preparation Optimization for INpatients- COIN Study Phase 4 Recruiting
NCT01778192 2012-07-01 A Randomized Prospective Trial Comparing Polyethylene Glycol and Sodium Picosulphate With Magnesium Citrate Phase 3 Completed
NCT01596335 2012-05-01 Clinical Study of TA-650 in Patients With Refractory Kawasaki Disease Phase 3 Active, Not Recruiting
NCT01519947 2012-05-01 A Study of The Effect of Altitude on Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) Dose Requirements in Patients With Chronic Renal Anemia in Pre-Dialysis or Dialysis Phase 4 Active, Not Recruiting
NCT02049346 2012-03-01 Comparison Among Erythropoietin Stimulating Agents Phase 4 Completed
NCT01797770 2012-01-01 Trial on Mechanical Bowel Preparation in Laparoscopic Colorectal Surgery Phase 4 Recruiting
NCT01510977 2011-11-01 Second Bowel Preparation for Colonoscopy Failure Phase 4 Terminated
NCT01649674 2011-11-01 Comparison of Bowel Cleansing Regimens Prior to Colonoscopy Phase 4 Recruiting
NCT01427296 2011-08-01 Safety and Efficacy of OsmoPrep® Tablets Versus HalfLytely® and Bisacodyl Tablet Bowel Prep Kit for Colon Cleansing Phase 4 Active, Not Recruiting
NCT01342640 2011-07-01 A Study of Mircera (C.E.R.A.) in Patients With Pre-Dialysis Chronic Renal Anemia Phase 4 Completed
NCT01287585 2011-07-01 Ph 3 ADI-PEG 20 Versus Placebo in Subjects With Advanced Hepatocellular Carcinoma Who Have Failed Prior Systemic Therapy Phase 3 Active, Not Recruiting
NCT01415687 2011-05-01 Split Dose Pico-Salax + Bisacodyl vs. PEG Split Dose Phase 3 Completed
NCT01711437 2011-01-01 Different Bowel Preparations for Colonoscopy In Children Phase 4 Recruiting
NCT00559637 2011-01-01 A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease Not Treated With ESA or on Dialysis. Phase 3 Completed
NCT00517413 2010-12-01 LATINO Study: A Study of Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia. Phase 3 Completed
NCT00560404 2010-12-01 A Study of Subcutaneous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia. Phase 3 Completed
NCT01531140 2010-11-01 PEG Versus PEG+Bisacodyl Versus Sennosides for Colon Cleansing Before Colonoscopy Phase 4 Completed
NCT01156363 2010-11-01 A Study of Monthly Subcutaneous or Intravenous Mircera in Dialysis Patients With Chronic Renal Anaemia Phase 4 Completed
NCT01140295 2010-09-01 Bowel Preparation for Colonoscopy in Children Phase 4 Terminated
NCT01267981 2010-09-01 Efficacy of Small Bowel Preparation in Capsule Endoscopy Phase 3 Recruiting
NCT01212445 2010-09-01 Dose-Finding Trial of Polyethylene Glycol 3350 Laxative Plus Electrolytes for the Treatment of Constipation (Protocol P07515) Phase 3 Completed
NCT01191983 2010-08-01 A Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) for the Treatment of Chronic Renal Anaemia in Patients With Diabetic Nephropathy Phase 4 Recruiting
NCT01229800 2010-08-01 Efficacy, Safety and Tolerability of Split-dose of PEG Compared With NaP Solution for Colonoscopy Preparation: A Randomized, Controlled Trial Phase 3 Completed
NCT01592734 2010-05-01 Efficacy and Tolerability of PEG-only Laxative for Fecal Impaction and Chronic Constipation in Children Phase 4 Completed
NCT01513811 2010-02-01 Itopride as an Adjuvant for Bowel Preparation in Patients With Chronic Constipation is Effective Phase 2 Completed
NCT00576602 2010-02-01 A Study of Subcutaneous Mircera, Versus no Erythropoiesis-Stimulating Agent (ESA) Therapy, in the Treatment of Anemia in Patients With Chronic Kidney Disease After Kidney Transplant Phase 4 Terminated
NCT00925782 2010-01-01 A Pharmacokinetic Study of Melphalan HCL for Injection (Propylene Glycol-Free) and Alkeran for Injection for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation Phase 2 Completed
NCT01065857 2010-01-01 Safety and Efficacy Study of CitraFleet (Sodium Picosulphate) as an Evacuating Treatment Prior to Colonoscopy. Phase 3 Completed
NCT01044394 2010-01-01 Same-day, Reduced Volume Bowel Preparation Phase 2 Withdrawn
NCT01066000 2009-10-01 A Study for Monthly Methoxy Polyethylene Glycol-Epoetin Beta Treatment in Patients With Chronic Renal Anaemia Phase 4 Completed
NCT00953017 2009-07-01 A Trial Comparing Split-Dose Miralax With Amitiza Pretreatment Versus Dulcolax Pretreatment Versus Golytely for Bowel Cleansing Prior to Colonoscopy Phase 4 Completed
NCT00773331 2009-07-01 A Study Comparing Maintenance of Hemoglobin Levels, Safety and Tolerability of Once Every 4 Weeks Mircera Versus Epoetin Beta in Dialysis Patients With Chronic Renal Anemia. Phase 3 Completed
NCT00889655 2009-05-01 A Trial Comparing Bowel Preparation and Patient Tolerability of Miralax Versus Golytely Phase 4 Not Yet Recruiting
NCT00922116 2009-04-01 A Study of Once Monthly Subcutaneous Mircera in Patients With Chronic Renal Anemia Not on Dialysis Phase 4 Completed
NCT00680563 2009-04-01 A Study of Once-Monthly Subcutaneous Mircera for the Treatment of Chronic Renal Anemia in Pre-Dialysis Patients Not Currently Treated With ESA. Phase 3 Terminated
NCT00882713 2009-02-01 A Study of Once Monthly Subcutaneous Mircera in Dialysis Patients With Chronic Renal Anemia Phase 3 Completed
NCT00922610 2009-02-01 A Study of Mircera in Renal Anemia Among Filipino Chronic Kidney Disease Patients Phase 4 Completed
NCT00856843 2009-02-01 BLI800-303: An Efficacy Evaluation of 2 Different Bowel Cleansing Preparations in Adult Subjects Phase 3 Completed
NCT00773513 2008-12-01 A Study of All-Cause Mortality and Cardiovascular Morbidity in CKD Patients on Dialysis and Those Not on Renal Replacement Therapy Receiving Mircera or Reference ESAs. Phase 4 Active, Not Recruiting
NCT00717821 2008-10-01 A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis. Phase 3 Completed
NCT00773968 2008-10-01 ORION Study: A Study of Monthly Subcutaneous Mircera in Predialysis Patients With Chronic Renal Anemia Phase 3 Completed
NCT00722410 2008-09-01 Probiotics for Eradication of Carbapenem Resistant Klebsiella Pneumonia Phase 1/Phase 2 Not Yet Recruiting
NCT00737477 2008-09-01 MISTRAL Study: A Study of Monthly Subcutaneous Mircera for Maintenance Treatment of Patients With Chronic Kidney Disease on Peritoneal Dialysis. Phase 3 Completed
NCT00661388 2008-08-01 A Study of Monthly Subcutaneous Mircera for the Treatment of Chronic Renal Anemia in Predialysis Patients Not Treated With ESA. Phase 3 Completed
NCT00756548 2008-08-01 BLI850-302: BLI850 vs an Approved Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy Phase 3 Completed
NCT00737464 2008-08-01 A Study of Once Monthly Intravenous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia. Phase 4 Completed
NCT00756977 2008-08-01 BLI850 vs an Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy Phase 3 Completed
NCT00717366 2008-07-01 A Study of Intravenous Mircera for the Treatment of Anemia in Pediatric Patients on Hemodialysis Phase 2 Recruiting
NCT00737711 2008-07-01 A Study of Two-Weekly Intravenous Mircera for the Treatment of Dialysis Patients With Chronic Renal Anemia Not Receiving ESA Therapy. Phase 4 Completed
NCT00699348 2008-07-01 CARISMA Study: A Study of Monthly Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia. Phase 3 Completed
NCT00660023 2008-06-01 A Study of Intravenous Mircera in Patients With Chronic Renal Anemia Who Are on Dialysis. Phase 3 Completed
NCT00642967 2008-05-01 A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis Phase 3 Completed
NCT00661505 2008-05-01 A Study of Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia Phase 3 Completed
NCT00576628 2008-04-01 A Study of Subcutaneous Mircera for the Treatment of Anemia in Pre-Dialysis Patients. Phase 3 Completed
NCT00642668 2008-04-01 A Study of Subcutaneous Mircera for the Maintenance Treatment of Patients With Chronic Renal Anemia Not Receiving ESA Treatment or Dialysis. Phase 4 Completed
NCT00677794 2008-03-01 Small Bowel Cleansing Prior to Video Capsule Endoscopy Examination Phase 4 Active, Not Recruiting
NCT00642304 2008-03-01 A Study of Subcutaneous Mircera for the Maintenance Treatment of Patients With Chronic Renal Anemia Not on Dialysis. Phase 3 Completed
NCT00462384 2008-02-01 A Study of Subcutaneous Mircera for the Treatment of Anemia in Pre-Dialysis Patients With Chronic Kidney Disease. Phase 3 Completed
NCT00687830 2008-02-01 Efficacy of Morning-only Bowel Preparation for Afternoon Colonoscopy. Phase 3 Completed
NCT00576303 2008-02-01 A Study of Intravenous Mircera in Dialysis Patients With Chronic Renal Disease and Anemia. Phase 3 Completed
NCT00550680 2008-02-01 A Study of Mircera for the Maintenance Treatment of Patients With Chronic Renal Anemia. Phase 3 Completed
NCT00603681 2008-01-01 Comparison of PEG Solutions With and Without Electrolytes in the Treatment of Constipation Phase 4 Completed
NCT00605345 2007-12-01 A Study Comparing Subcutaneous Mircera and Darbepoetin Alfa for the Maintenance Treatment of Anemia in Kidney Transplant Recipients. Phase 3 Completed
NCT00559273 2007-12-01 A Study of Subcutaneous Mircera Once Monthly in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis. Phase 3 Completed
NCT00605293 2007-12-01 A Study of Intravenous Mircera for the Maintenance Treatment of Hemodialysis Patients With Chronic Renal Anemia Phase 3 Completed
NCT00642850 2007-11-01 STABIL Study: National Study With Mircera for Maintenance of Hemoglobin Level in Dialysis Patients Phase 3 Completed
NCT00546481 2007-11-01 A Study of Intravenous Mircera for the Correction of Anemia in Dialysis Patients. Phase 3 Completed
NCT00770432 2007-11-01 Study Comparing PEG 3350 Laxative to Placebo in the Treatment of Occasional Constipation (Study CL2007-12)(P08216) Phase 4 Completed
NCT00545571 2007-10-01 MIRACLE Study: A Study Of Once-Monthly Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia. Phase 3 Completed
NCT00560547 2007-10-01 A Study of Once-Monthly Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia. Phase 3 Withdrawn
NCT00503815 2007-07-01 BLI-800-302: BLI-800 vs an Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy Phase 3 Completed
NCT00503607 2007-07-01 BLI-800-301: BLI-800 vs an Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy Phase 3 Completed
NCT00517881 2007-07-01 A Study of Subcutaneous Mircera for the Maintenance Treatment of Pre-Dialysis Patients With Chronic Renal Anemia. Phase 3 Completed
NCT00442793 2007-05-01 A Study Comparing Mircera and Epoetin Beta for the Treatment of Anemia in Dialysis Patients With Chronic Kidney Disease. Phase 3 Completed
NCT00454246 2007-04-01 A Study of Mircera in Hemoglobin Control of Patients Transitioning to Dialysis. Phase 3 Terminated
NCT00422513 2007-03-01 A Study Comparing Mircera and Epoetin Alfa for the Treatment of Anemia in Dialysis Patients With Chronic Kidney Disease. Phase 3 Terminated
NCT00442416 2007-02-01 A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients. Phase 3 Terminated
NCT00413894 2007-02-01 A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients. Phase 3 Completed
NCT00394953 2007-01-01 A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients. Phase 3 Completed
NCT00607776 2007-01-01 Artificial Tears Study in Mild to Moderate Dry Eye Patients Phase 2 Completed
NCT00472966 2006-11-01 Efficacy and Safety of Therapy With Tri-Luma® Cream in Sequence With Glycolic Acid Peels for Melasma Phase 4 Completed
NCT00327535 2006-05-01 A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving First Line Chemotherapy. Phase 2 Completed
NCT01783782 2005-11-01 Small Bowel Cleansing for Capsule Endoscopy in Pediatric Patients Phase 4 Recruiting
NCT00171522 2005-05-01 Preference of Tegaserod vs. PEG 3350 in Patients With Constipation Phase 4 Completed
NCT00108160 2005-04-01 Preventing Staphylococcal (Staph) Infection Phase 4 Completed
NCT00090753 2004-10-01 A Study of Intravenous or Subcutaneous Methoxy Polyethylene Glycol-Epoetin Beta (RO0503821, Mircera) in Chronic Kidney Disease Patients With Renal Anemia Phase 3 Completed
NCT00081471 2004-06-01 A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis Phase 3 Completed
NCT00081484 2004-06-01 A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients Phase 3 Completed
NCT00077623 2004-03-01 A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients. Phase 3 Completed
NCT00077766 2004-03-01 A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients. Phase 3 Completed
NCT00077597 2004-02-01 A Study of Mircera for the Treatment of Anemia in Dialysis Patients Phase 3 Completed
NCT00077610 2004-02-01 A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients Phase 3 Completed
NCT00072059 2003-07-01 Ro 50-3821 in Treating Anemia in Patients Receiving Antineoplastic Therapy for Stage IIIB or Stage IV Non-Small Cell Lung Cancer Phase 2 Completed
NCT00403819 2002-04-01 Study to Examine the Efficacy and Safety of Movicol in the Treatment of Chronic Constipation in Children Phase 3 Completed
NCT00048048 2002-03-01 A Study of Mircera in Anemic Patients With Chronic Kidney Disease Not Yet on Dialysis. Phase 2 Completed
NCT00048035 2002-02-01 A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia Phase 2 Completed
NCT00364832 2001-10-01 A Study of Subcutaneous (sc) Mircera in Dialysis Patients With Chronic Renal Anemia. Phase 2 Completed
NCT00403897 2001-08-01 An Open Single Centre Study To Assess Treatment of Chronic Constipation in Children Phase 3 Completed
NCT00404040 2000-10-01 Movicol in Childhood Constipation (ProMotion Study) Phase 2 Completed
NCT00403858 2000-10-01 Movicol in Childhood Constipation (ProMotion Study) Phase 2 Completed

(Browse) Purchasable Analogs in ZINC

Functions of Propylene Glycol

Misc - Miscellaneous

Dosages

Route Formulation Per Unit Dose
Auricular (otic) Drops
Auricular (otic) Solution, Drops
Auricular (otic) Suspension 10%
Buccal Film 1.48MG
Buccal Film, Soluble 1.02MG
Dental Ointment
Dental Paste
Dental Solution 2%
Extracorporeal Solution 5%
Im - Iv Injection 82.04%
Im - Iv Solution, Injection 41.6%
Inhalation Solution 25%
Intramuscular Injection 40%
Intramuscular Powder, For Injection Solution
Intramuscular Solution, Injection 40%
Intravenous Infusion
Intravenous Injectable 30%
Intravenous Injection 50%
Intravenous Solution, Concentrate 50.33%
Intravenous Solution, Injection 30%
Iv(infusion) Injectable 20.8%
Iv(infusion) Solution, Injection 30%
Nasal Solution 12%
Nasal Spray, Metered 20%
Ophthalmic Gel 0.44%
Ophthalmic Solution 10%
Ophthalmic Solution, Drops 0.75%
Ophthalmic Suspension 5%
Ophthalmic Suspension, Drops 1%
Oral Capsule 52MG
Oral Capsule, Delayed Action, Enteric Coated
Oral Capsule, Enteric Coated Pellets 1.7MG
Oral Capsule, Extended Release 0.02MG
Oral Capsule, Soft Gelatin 148.31MG
Oral Capsule, Soft Gelatin Liquid-Filled 17.7MG
Oral Capsule, Sustained Action 14.6MG
Oral Concentrate 70%
Oral Drops 0.13%
Oral Liquid 21%
Oral Powder 5.5%
Oral Solution, Concentrate 51.8%
Oral Solution, Elixir 20.72%
Oral Solution, Syrup 12.2%
Oral Spray 3.75%
Oral Suspension, Liquid 5%
Oral Suspension, Sustained Action 3%
Oral Syrup 50%
Oral Tablet (immed./comp. Release), Film Coated 0.21MG
Oral Tablet, Coated 1.5MG
Oral Tablet, Controlled Release
Oral Tablet, Delayed Action 5.83MG
Oral Tablet, Delayed Action, Enteric Coated 6.95MG
Oral Tablet, Delayed Release 5.97MG
Oral Tablet, Enteric Coated Particles 4.3MG
Oral Tablet, Extended Release 1.34MG
Oral Tablet, Sustained Action 9MG
Oral Tablet, Sustained Action, Coated
Oral Tablet, Sustained Action, Film Coated 12.8MG
Photopheresis Solution 5%
Rectal Aerosol, Metered 18%
Rectal Emulsion, Aerosol Foam 47.04%
Rectal Gel 82.88%
Rectal Ointment 2%W/W
Rectal Suspension 11.3%
Route Not Given Solution, Injection
Subcutaneous Injection 1.4%
Subcutaneous Solution, Injection 0.47%
Sublingual Spray 0.45%
Topical Aerosol 19.2%W/W
Topical Aerosol, Metered
Topical Cream 69%W/W
Topical Cream, Augmented 30%
Topical Cream, Emulsion, Sustained Release 69.5%
Topical Emulsion 8%
Topical Emulsion, Aerosol Foam 21.05%
Topical Emulsion, Cream 71.08%W/W
Topical Emulsion, Lotion 47.5%
Topical Film, Controlled Release
Topical Gel 98.09%
Topical Lotion 30%
Topical Lotion, Augmented 30%
Topical Ointment 38%
Topical Ointment, Augmented 65%
Topical Patch
Topical Patch, Controlled Release
Topical Shampoo 3.5%
Topical Shampoo, Suspension 2%
Topical Solution 61.5%
Topical Solution, Liquid 5%
Topical Sponge
Topical Suppository
Topical Suppository, Insert
Topical Suspension 5.28%W/V
Topical Swab
Transdermal Film, Controlled Release 58.13MG
Transdermal Gel 20%
Vaginal Emulsion, Aerosol Foam 6.4%
Vaginal Gel 3%
Vaginal Suppository 252MG
Vaginal Tampon 62.1MG

More Information

Usage Over Time

Comments